Scarica l'app Stockscreener
51.10
3.00%
-1.58
Dopo l'orario di chiusura:
51.15
0.05
+0.10%
Tempus Ai Inc Borsa (TEM) Ultime notizie
Multiple Class A Common sales reported by holders (NASDAQ: TEM) - Stock Titan
Tempus AI (TEM) to Release Earnings on Tuesday - MarketBeat
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - The Joplin Globe
Artificial Intelligence Stocks Worth WatchingApril 27th - MarketBeat
Tempus AI (TEM) Proxy filing Summary - Quartr
Tempus AI will acquire Paige for $81.25M - MSN
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy? - Yahoo Finance
Tempus AI, Inc. $TEM Stake Cut by Renaissance Capital LLC - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Uncovering the Potential 38.91% Upside with Cutting-Edge Healthcare Technology - DirectorsTalk Interviews
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? - MSN
Artificial Intelligence Stocks To ConsiderApril 26th - MarketBeat
Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat? - simplywall.st
Best Artificial Intelligence Stocks To Watch NowApril 25th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI Nears Profitability as Operating Leverage Emerges - The Globe and Mail
Artificial Intelligence Stocks To Watch NowApril 24th - MarketBeat
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door - TechStock²
Tempus AI (TEM) Stock Drops 7% Despite Landmark USC Medical Partnership - MEXC Exchange
Tempus AI (TEM) Stock Slides Even As USC Inks Major AI Health Deal - MEXC
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F - GlobeNewswire Inc.
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility? - Yahoo Finance
Tempus AI partners with USC’s Keck Medicine on precision care By Investing.com - Investing.com Australia
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine - BioSpace
Tempus AI shares gain after expanded partnership with Gilead - msn.com
Tempus AI Stock Falls After USC Deal, Putting Its Cancer Data Push To The Test - TechStock²
Healthcare AI Firm Sued Over Alleged Unlawful Disclosures of Genetic Data - The HIPAA Journal
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights - PharmiWeb.com
Promising Artificial Intelligence Stocks To Add to Your WatchlistApril 23rd - MarketBeat
USC and Tempus AI partner to advance precision medicine - News-Medical
FDA clears AI lung cancer tool; first U.S. sites set for Q3 - Stock Titan
Cathie Wood Is Loading Up on These 3 Next-Gen Tech Stocks - Yahoo Finance
USC and Tempus Join Forces in Strategic Partnership to Accelerate Innovation in Research and Patient Care - Bioengineer.org
TEM Stock Price and Chart — NASDAQ:TEM - TradingView
Tempus AI partners with USC’s Keck Medicine on precision care - Investing.com
TEM (Tempus AI Inc.) tops EPS estimates and posts 83 percent year over year revenue growth, shares fall 3.53 percent today.Crowd Risk Alerts - Xã Thanh Hà
Is Tempus AI (TEM) Pricing Reflect Its DCF Upside And Premium Sales Multiple - simplywall.st
Promising Artificial Intelligence Stocks To Keep An Eye OnApril 21st - MarketBeat
Tempus AI Inc. (TEM): Nancy Pelosi Likes This AI-Powered Medicine Company - Insider Monkey
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform - TradingView
Tempus to Report First Quarter 2026 Financial Results on May 5 - BioSpace
Press Release: Tempus to Report First Quarter 2026 Financial Results on May 5 - Moomoo
Tempus AI (TEM) Stock: Growth Outlook (On the Radar) 2026-04-20High Interest Stocks - Xã Thanh Hà
Artificial Intelligence Stocks To Add to Your WatchlistApril 20th - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 29.59% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration - MSN
Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock - Insider Monkey
Best Artificial Intelligence Stocks Worth WatchingApril 19th - MarketBeat
Promising Artificial Intelligence Stocks To Watch TodayApril 18th - MarketBeat
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Artificial Intelligence Stocks To Follow NowApril 17th - MarketBeat
2.22%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):